Sato Norio, Moore Frederick A, Smith Marshall A, Zou Lei, Moore-Olufemi Stacey, Schultz Stanley G, Kozar Rosemary A
Department of Surgery, University of Texas-Houston, Houston, Texas 77030, USA.
J Trauma. 2005 Mar;58(3):455-61; discussion 461. doi: 10.1097/01.ta.0000153937.04932.59.
Recent reports suggest that enteral diets enriched with arginine may be harmful by enhancing inflammation. This is consistent with our gut ischemia/reperfusion (I/R) model in which arginine induced the proinflammatory mediator inducible nitric oxide synthase and resulted in injury and inflammation whereas glutamine was protective. We now hypothesize that arginine and glutamine differentially modulate the early proinflammatory transcription factors activated by gut I/R.
At laparotomy, jejunal sacs were filled with either 60 mmol/L glutamine, arginine, or an iso-osmotic control followed by 60 minutes of superior mesenteric artery occlusion and 6 hours of reperfusion and compared with shams. Jejunum was harvested for nuclear factor (NF)-kappaB and activator protein-1 (AP-1) measured by electrophoretic mobility shift assay and c-jun and c-fos (AP-1 family) by supershift.
Both NF-kappaB and AP-1 were activated by gut I/R. Arginine and glutamine had no differential effect on NF-kappaB, whereas AP-1 expression (c-jun but not c-fos) was markedly enhanced by arginine and significantly lessened by glutamine.
Arginine enhanced expression of the early proinflammatory transcription factor AP-1 but not NF-kappaB. This represents a novel mechanism by which arginine may be harmful when administered to critically ill patients.
近期报告表明,富含精氨酸的肠内饮食可能通过加剧炎症而产生有害作用。这与我们的肠道缺血/再灌注(I/R)模型一致,在该模型中,精氨酸诱导促炎介质诱导型一氧化氮合酶的产生,并导致损伤和炎症,而谷氨酰胺则具有保护作用。我们现在推测,精氨酸和谷氨酰胺对肠道I/R激活的早期促炎转录因子具有不同的调节作用。
在剖腹手术中,空肠囊分别填充60 mmol/L的谷氨酰胺、精氨酸或等渗对照物,随后进行60分钟的肠系膜上动脉闭塞和6小时的再灌注,并与假手术组进行比较。采集空肠用于通过电泳迁移率变动分析测定核因子(NF)-κB和活化蛋白-1(AP-1),并通过超迁移分析测定c-jun和c-fos(AP-1家族)。
肠道I/R激活了NF-κB和AP-1。精氨酸和谷氨酰胺对NF-κB没有差异影响,而精氨酸显著增强了AP-1的表达(c-jun而非c-fos),谷氨酰胺则使其显著降低。
精氨酸增强了早期促炎转录因子AP-1的表达,但未增强NF-κB的表达。这代表了一种新的机制,通过该机制,精氨酸在应用于重症患者时可能产生有害作用。